マサチューセッツ州におけるクローン病の臨床試験
マサチューセッツ州内の拠点で、クローン病に関する27件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Massachusetts General Hospital, Boston
被験者募集中健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07033208A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Boston Childrens Hospital, Boston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/25更新 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Lucida Clinical Trials /ID# 266548, New Bedford
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, New Bedford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tufts Medical Center-Site Number: 8400126, Boston
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/23更新 · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Boston Children's Hospital, Boston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
被験者募集中第1/2相
12歳〜80歳 · 全性別 · 2026/08/03更新 · NCT04263831Cranberry and Gut Health in Crohn's Disease
- UMASS medical center, Worcester
被験者募集中早期第1相
18歳〜65歳 · 全性別 · 2026/07/20更新 · NCT07170462Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Boston Children's Hospital /ID# 262191, Boston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/24更新 · NCT06332534Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Boston Children's Hospital, Boston
被験者募集中第4相
6歳〜17歳 · 全性別 · 2026/05/27更新 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Boston Children's Hospital, Boston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/05/05更新 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, LLC, New Bedford
- University of Massachusetts, Worcester, Worcester
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/27更新 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400022, Boston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/03/27更新 · NCT06958536Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/03/12更新 · NCT06252493Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Massachusetts General Hospital, Boston
被験者募集中健康なボランティア歓迎
14歳以上 · 全性別 · 2026/01/30更新 · NCT05332639A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Massachusetts General Hospital, Boston
被験者募集中健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2025/12/16更新 · NCT07219537Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- Boston Children's Hospital, Boston
被験者募集中観察研究健康なボランティア歓迎
13歳〜20歳 · 全性別 · 2025/10/30更新 · NCT04508088High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
被験者募集中観察研究
5歳〜25歳 · 全性別 · 2025/03/03更新 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
被験者募集中観察研究健康なボランティア歓迎
14歳以上 · 全性別 · 2024/12/20更新 · NCT06655415ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。